Vienna - Delayed Quote EUR
Cencora, Inc. (ABC.VI)
252.20
+0.60
+(0.24%)
At close: 5:32:14 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 14 | 14 |
| Avg. Estimate | 75.8B | 81.36B | 323.6B | 345.51B |
| Low Estimate | 74.26B | 80.29B | 321.8B | 338.57B |
| High Estimate | 77.07B | 83.4B | 326.89B | 351.78B |
| Year Ago Sales | 68.41B | 74.24B | 293.96B | 323.6B |
| Sales Growth (year/est) | 10.79% | 9.59% | 10.08% | 6.77% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABC.VI | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 4/29/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 4/11/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/14/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 2/6/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/29/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 1/24/2025 |